| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |